Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arthrosan Plus is an over-the-counter (OTC) combination product developed and marketed by Brunel Laboratoria, primarily in the South African market. It is formulated as a joint health supplement intended to manage symptoms of osteoarthritis and support cartilage maintenance. The primary active ingredients are **glucosamine sulfate** and **chondroitin sulfate**. Glucosamine serves as a biological precursor for glycosaminoglycans and proteoglycans, which are essential components of the cartilage matrix. Chondroitin sulfate provides structural integrity to cartilage and may inhibit enzymes that contribute to cartilage degradation. Together, these components aim to reduce joint pain, decrease inflammation, and improve mobility in individuals with degenerative joint conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Arthrosan Plus.